We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$42.3B
AUM Growth
+$5.51B
Cap. Flow
+$3.13B
Cap. Flow %
7.41%
Top 10 Hldgs %
26.06%
Holding
1,338
New
111
Increased
793
Reduced
350
Closed
65

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$238M
2
CGAU
Centerra Gold
CGAU
+$212M
3
HAL icon
Halliburton
HAL
+$181M
4
BKR icon
Baker Hughes
BKR
+$115M
5
NOW icon
ServiceNow
NOW
+$103M

Sector Composition

Rank Sector Weight
1 Materials 40.42%
2 Technology 21.38%
3 Energy 8.67%
4 Healthcare 6.57%
5 Financials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTP
326
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$11.5M 0.03%
232,558
-49,060
-17% -$2.49M
X
327
DELISTED
US Steel
X
$11.5M 0.03%
478,722
+273,537
+133% +$6.73M
LADR
328
Ladder Capital
LADR
$1.21B
$11.5M 0.03%
993,044
+145,264
+17% +$1.7M
NZF icon
329
Nuveen Municipal Credit Income Fund
NZF
$2.4B
$11.4M 0.03%
660,702
+49,673
+8% +$833K
AESC
330
DELISTED
The AES Corporation
AESC
$11.3M 0.03%
105,460
-1,099
-1% -$116K
GAU
331
Galiano Gold
GAU
$455M
$11.3M 0.03%
10,401,135
+457,273
+5% +$556K
TX icon
332
Ternium
TX
$9.67B
$11.1M 0.03%
289,372
+128,500
+80% +$4.9M
CCI icon
333
Crown Castle
CCI
$33.3B
$11.1M 0.03%
56,752
+6,581
+13% +$1.23M
NBIX icon
334
Neurocrine Biosciences
NBIX
$16.8B
$11M 0.03%
113,390
+8,838
+8% +$847K
GORO icon
335
Goldgroup Mining Inc.
GORO
$157M
$11M 0.03%
4,267,007
-42,354
-1% -$117K
GFLU
336
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
$11M 0.03%
146,572
-21,311
-13% -$1.63M
GSV
337
DELISTED
Gold Standard Ventures Corp.
GSV
$10.9M 0.03%
19,527,016
-1,570,805
-7% -$923K
CNI icon
338
Canadian National Railway
CNI
$76.9B
$10.8M 0.03%
102,803
+8,659
+9% +$956K
GSK icon
339
GSK
GSK
$104B
$10.7M 0.03%
215,099
-19,221
-8% -$924K
USAS
340
Americas Gold and Silver
USAS
$1.29B
$10.7M 0.03%
2,812,430
+219,754
+8% +$1.07M
SO icon
341
Southern Company
SO
$109B
$10.6M 0.03%
175,117
+12,827
+8% +$820K
TAK icon
342
Takeda Pharmaceutical
TAK
$54.6B
$10.5M 0.02%
622,965
+60,231
+11% +$1.03M
SLRC icon
343
SLR Investment Corp
SLRC
$686M
$10.5M 0.02%
561,031
-70,630
-11% -$1.32M
SID icon
344
Companhia Siderúrgica Nacional
SID
$1.31B
$10.4M 0.02%
1,186,520
+305,680
+35% +$2.65M
VSTA
345
DELISTED
Vasta Platform
VSTA
$10.3M 0.02%
1,266,862
+15,000
+1% +$133K
CTLT
346
DELISTED
CATALENT, INC.
CTLT
$10.2M 0.02%
94,255
-609
-0.6% -$65.3K
GSS
347
DELISTED
Golden Star Resources Ltd.
GSS
$10.1M 0.02%
3,585,089
-758,954
-17% -$2.54M
LI icon
348
Li Auto
LI
$13.4B
$10.1M 0.02%
+289,899
New +$6.79M
LVS icon
349
Las Vegas Sands
LVS
$31.7B
$10.1M 0.02%
190,807
+11,565
+6% +$668K
IWD icon
350
iShares Russell 1000 Value ETF
IWD
$82.2B
$10M 0.02%
63,213
+21,574
+52% +$3.42M

Similar funds

VanEck Associates's Q2 2021 Portfolio in Review

As of Q2 2021, VanEck Associates held 1,338 positions worth $42.3B, up 15% from $36.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

VanEck Associates deployed $3.13B of net new capital in Q2 2021, opening 111 new positions and adding to 793 existing holdings. Its largest new stake was Centerra Gold: 25,491,475 shares worth $193M.

By sector, the portfolio is most concentrated in Materials at 40% of assets, down from 43% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Gold Fields, an estimated $374M trimmed.

  • VanEck Associates's largest Q2 2021 buy was Centerra Gold: 25,491,475 shares worth $193M.
  • VanEck Associates added most to SLB Ltd in Q2 2021, an estimated $238M increase.
  • VanEck Associates's biggest Q2 2021 reduction was Gold Fields, cutting an estimated $374M.
  • VanEck Associates fully exited John Wiley & Sons Class A in Q2 2021, selling an estimated $96.5M.
  • VanEck Associates's ten largest holdings make up 26% of its $42.3B portfolio in Q2 2021.
  • VanEck Associates opened 111 new positions and closed 65 in Q2 2021.
  • VanEck Associates's portfolio value rose 15% quarter-over-quarter to $42.3B.

Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.